Sofinnova Investments, Inc.
An institutional investment manager in Menlo Park, CA. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 14, 2026. SEC CIK 1631134.
- Reported value$1.93bn
- Positions57
Holdings: 57 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Natera IncNTRA | COM | 632307104 | 421 | 21.8% | 1,550,280 | Unchanged | |
| Vera Therapeutics IncVERA | CL A | 92337R101 | 120 | 6.2% | 2,793,987 | Unchanged | |
| Genmab A/SGMAB | SPONSORED ADS | 372303206 | 111 | 5.7% | 4,045,215 | Added+3,292,954 | |
| Jazz Pharmaceuticals PLC | SHS USD | G50871105 | 88.0 | 4.6% | 365,341 | Reduced−232,986 | |
| Rapport Therapeutics IncRAPP | COM | 75383L102 | 79.4 | 4.1% | 1,904,408 | Unchanged | |
| Seaport Therapeutics IncSPTX | COM | 81221K108 | 77.4 | 4.0% | 3,564,871 | New+3,564,871 | |
| Arrivent BioPharma IncAVBP | COM | 04272N102 | 58.9 | 3.0% | 1,696,752 | Unchanged | |
| Ultragenyx Pharmaceutical InRARE | COM | 90400D108 | 57.3 | 3.0% | 1,717,505 | Reduced−1,428,383 | |
| BioAge Labs IncBIOA | COM | 09077V100 | 56.2 | 2.9% | 2,293,788 | Unchanged | |
| Bristol-Myers Squibb CoBMY | COM | 110122108 | 50.5 | 2.6% | 876,970 | Reduced−1,111,751 | |
| Supernus PharmaceuticalsSUPN | COM | 868459108 | 48.2 | 2.5% | 1,036,328 | Added+82,019 | |
| Rhythm Pharmaceuticals IncRYTM | COM | 76243J105 | 45.3 | 2.3% | 408,027 | Reduced−42,069 | |
| Gilead Sciences IncGILD | COM | 375558103 | 43.3 | 2.2% | 343,100 | New+343,100 | |
| United Therapeutics Corp DelUTHR | COM | 91307C102 | 41.4 | 2.1% | 76,489 | Reduced−83,581 | |
| Cogent Biosciences IncCOGT | COM | 19240Q201 | 40.1 | 2.1% | 1,035,148 | Reduced−1,078,403 | |
| Axsome Therapeutics Inc.AXSM | COM | 05464T104 | 39.3 | 2.0% | 160,429 | Reduced−52,318 | |
| Immatics N.V | SHS | N44445109 | 37.2 | 1.9% | 3,669,346 | Added+38,892 | |
| Dyne Therapeutics IncDYN | COM | 26818M108 | 36.8 | 1.9% | 1,658,384 | Added+24,487 | |
| Immunome IncIMNM | COM | 45257U108 | 36.5 | 1.9% | 1,720,316 | Added+18,412 | |
| IDEAYA Biosciences IncIDYA | COM | 45166A102 | 34.5 | 1.8% | 925,119 | Reduced−206,667 | |
| Anaptysbio IncANAB | COM | 032724106 | 33.3 | 1.7% | 493,536 | Added+245,283 | |
| Nektar TherapeuticsNKTR | COM NEW | 640268306 | 32.9 | 1.7% | 471,763 | Reduced−37,783 | |
| Pharvaris N V | COM | N69605108 | 30.5 | 1.6% | 881,299 | Added+62,971 | |
| Arcus Biosciences IncRCUS | COM | 03969F109 | 29.2 | 1.5% | 945,690 | Added+22,604 | |
| Inhibrx Biosciences IncINBX | COM | 45720N103 | 28.7 | 1.5% | 303,103 | Reduced−102,926 | |
| BioMarin Pharmaceutical IncBMRN | COM | 09061G101 | 20.5 | 1.1% | 358,568 | Reduced−423,414 | |
| Veradermics IncMANE | COMMON STOCK | 922967104 | 18.3 | 0.9% | 148,993 | Added+75,678 | |
| Alcon AG | ORD SHS | H01301128 | 17.2 | 0.9% | 255,824 | Reduced−474,148 | |
| Insmed IncINSM | COM PAR $.01 | 457669307 | 16.9 | 0.9% | 158,398 | Reduced−187,677 | |
| Ultragenyx Pharmaceutical InRARE | COM | 90400D108 | 16.7 | 0.9% | 500,000 | Call | Added+150,000 |
| Intuitive Surgical IncISRG | COM NEW | 46120E602 | 15.9 | 0.8% | 40,000 | Call | New+40,000 |
| Globus Med IncGMED | CL A | 379577208 | 15.8 | 0.8% | 200,000 | Call | New+200,000 |
| Edgewise Therapeutics IncEWTX | COM | 28036F105 | 15.5 | 0.8% | 380,923 | Reduced−5,575 | |
| Exelixis IncEXEL | COM | 30161Q104 | 13.8 | 0.7% | 254,200 | Put | Added+2,700 |
| Nurix Therapeutics IncNRIX | COM | 67080M103 | 12.7 | 0.7% | 524,098 | New+524,098 | |
| Design Therapeutics IncDSGN | COM | 25056L103 | 12.5 | 0.6% | 865,135 | New+865,135 | |
| Definium Therapeutics IncDFTX | COM SHS | 24477V105 | 12.0 | 0.6% | 255,903 | Reduced−88,263 | |
| First Tracks BiotherapeuticsTRAX | ORD SHS | 337185102 | 11.4 | 0.6% | 565,199 | New+565,199 | |
| Abbott LaboratoriesABT | COM | 002824100 | 11.2 | 0.6% | 122,998 | New+122,998 | |
| Disc Medicine IncIRON | COM | 254604101 | 10.7 | 0.6% | 146,239 | Added+67,919 | |
| Tenax Therapeutics IncTENX | COM NEW | 88032L605 | 7.3 | 0.4% | 500,039 | Added+395,639 | |
| Sionna Therapeutics IncSION | COM | 829401108 | 6.4 | 0.3% | 144,432 | New+144,432 | |
| Absci CorporationABSI | COM | 00091E109 | 3.9 | 0.2% | 337,400 | New+337,400 | |
| Mirum Pharmaceuticals IncMIRM | COM | 604749101 | 3.2 | 0.2% | 27,591 | Unchanged | |
| Jade Biosciences IncJBIO | COM | 008064206 | 2.4 | 0.1% | 107,391 | Unchanged | |
| Savara IncSVRA | COM | 805111101 | 2.2 | 0.1% | 364,763 | Unchanged | |
| Praxis Precision Medicines IPRAX | COM NEW | 74006W207 | 2.2 | 0.1% | 6,440 | Reduced−57,240 | |
| Septerna IncSEPN | COM | 81734D104 | 1.6 | <0.1% | 47,506 | Unchanged | |
| Onkure Therapeutics IncOKUR | COM CL A | 68277Q105 | 1.5 | <0.1% | 321,692 | Added+179,992 | |
| Sagimet Biosciences IncSGMT | COM SER A | 786700104 | 1.3 | <0.1% | 166,667 | New+166,667 | |
| Wave Life Sciences Ltd | SHS | Y95308105 | 1.1 | <0.1% | 189,253 | Unchanged | |
| Aktis Oncology IncAKTS | COM | 01021M104 | 1.0 | <0.1% | 32,436 | New+32,436 | |
| Tyra Biosciences IncTYRA | COM | 90240B106 | 1.0 | <0.1% | 32,267 | Reduced−171,748 | |
| Bolt Biotherapeutics IncBOLT | COM | 097702203 | 0.5 | <0.1% | 137,721 | Unchanged | |
| Nextcure IncNXTC | COM | 65343E207 | 0.4 | <0.1% | 222,654 | Unchanged | |
| ImageneBio IncIMA | COM | 45175G207 | 0.2 | <0.1% | 31,884 | Unchanged | |
| Heartflow IncHTFL | COM | 42238D107 | 0.1 | <0.1% | 5,079 | New+5,079 |
Sold out: 30 positions
Held at the end of the quarter before and not reported this quarter.
| Issuer | Class | CUSIP | Reported value$ | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Acadia Pharmaceuticals IncACAD | COM | 004225108 | 0.0 | 0.0% | 0 | Sold out−78,551 | |
| AstraZeneca PLC | ORD | G0593M107 | 0.0 | 0.0% | 0 | Sold out−456,031 | |
| AxoGen IncAXGN | COM | 05463X106 | 0.0 | 0.0% | 0 | Sold out−210,665 | |
| Axsome Therapeutics Inc.AXSM | COM | 05464T104 | 0.0 | 0.0% | 0 | Put | Sold out−200,000 |
| Biogen IncBIIB | COM | 09062X103 | 0.0 | 0.0% | 0 | Sold out−229,521 | |
| BridgeBio Pharma IncBBIO | COM | 10806X102 | 0.0 | 0.0% | 0 | Sold out−409,183 | |
| Celcuity IncCELC | COM | 15102K100 | 0.0 | 0.0% | 0 | Put | Sold out−300,000 |
| Celcuity IncCELC | COM | 15102K100 | 0.0 | 0.0% | 0 | Sold out−366,175 | |
| Compass Therapeutics IncCMPX | COM | 20454B104 | 0.0 | 0.0% | 0 | Sold out−2,056,161 | |
| Compass Therapeutics IncCMPX | COM | 20454B104 | 0.0 | 0.0% | 0 | Call | Sold out−500,000 |
| Cytokinetics IncCYTK | COM | 23282W605 | 0.0 | 0.0% | 0 | Sold out−91,791 | |
| Dexcom IncDXCM | COM | 252131107 | 0.0 | 0.0% | 0 | Sold out−393,576 | |
| Establishment Labs Hldgs Inc | COM | G31249108 | 0.0 | 0.0% | 0 | Sold out−33,930 | |
| Harmony Biosciences Hldgs IncHRMY | COM | 413197104 | 0.0 | 0.0% | 0 | Sold out−152,695 | |
| Invesco QQQ TR | UNIT SER 1 | 46090E103 | 0.0 | 0.0% | 0 | Put | Sold out−150,000 |
| iShares TR | ISHARES BIOTECH | 464287556 | 0.0 | 0.0% | 0 | Put | Sold out−475,000 |
| iShares TR | RUSSELL 2000 ETF | 464287655 | 0.0 | 0.0% | 0 | Put | Sold out−600,000 |
| Liquidia CorporationLQDA | COM | 53635D202 | 0.0 | 0.0% | 0 | Put | Sold out−500,000 |
| Oric Pharmaceuticals IncORIC | COM | 68622P109 | 0.0 | 0.0% | 0 | Sold out−679,578 | |
| Pfizer IncPFE | COM | 717081103 | 0.0 | 0.0% | 0 | Call | Sold out−800,000 |
| Replimune Group IncREPL | COM | 76029N106 | 0.0 | 0.0% | 0 | Call | Sold out−1,015,400 |
| Roivant Sciences Ltd | SHS | G76279101 | 0.0 | 0.0% | 0 | Sold out−477,995 | |
| Soleno Therapeutics Inc | COM | 834203309 | 0.0 | 0.0% | 0 | Sold out−14,689 | |
| SPDR Series Trust | STATE STREET SPD | 78464A870 | 0.0 | 0.0% | 0 | Put | Sold out−1,050,000 |
| Stryker CorporationSYK | COM | 863667101 | 0.0 | 0.0% | 0 | Sold out−44,480 | |
| Tango Therapeutics IncTNGX | COM | 87583X109 | 0.0 | 0.0% | 0 | Sold out−395,081 | |
| United Therapeutics CorpUTHR | COM | 91307C102 | 0.0 | 0.0% | 0 | Put | Sold out−80,300 |
| Vaxcyte IncPCVX | COM | 92243G108 | 0.0 | 0.0% | 0 | Sold out−50,600 | |
| Xenon Pharmaceuticals IncXENE | COM | 98420N105 | 0.0 | 0.0% | 0 | Sold out−305,216 | |
| Zymeworks IncZYME | COM | 98985Y108 | 0.0 | 0.0% | 0 | Sold out−1,610 |
Source: SEC EDGAR, Form 13F-HR, accession 0001104659-26-096982 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.